Barrichello APC, Elkrief A, Ricciuti B, Ganta T, et al. Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (>/=50%) Patients. Clin Lung Cancer 2025 Feb 4:S1525-7304(25)00025.
PMID: 40021433